SPG11 anticorps (AA 2019-2318) (HRP)
Aperçu rapide pour SPG11 anticorps (AA 2019-2318) (HRP) (ABIN7170427)
Antigène
Voir toutes SPG11 AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Épitope
- AA 2019-2318
-
Réactivité croisée
- Humain
-
Purification
- >95%, Protein G purified
-
Immunogène
- Recombinant Human Spatacsin protein (2019-2318AA)
-
Isotype
- IgG
-
-
-
-
Indications d'application
- Optimal working dilution should be determined by the investigator.
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Buffer
-
Preservative: 0.03 % Proclin 300
Constituents: 50 % Glycerol, 0.01M PBS, PH 7.4 -
Agent conservateur
- ProClin
-
Précaution d'utilisation
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Stock
- -20 °C,-80 °C
-
Stockage commentaire
- Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
-
-
- SPG11 (Spastic Paraplegia 11 (Autosomal Recessive) (SPG11))
-
Autre désignation
- SPG11
-
Sujet
-
Background: cytoplasm, cytoplasmic vesicle, extracellular exosome, lysosomal membrane, nucleolus, plasma membrane
Aliases: Colorectal carcinoma associated protein antibody, Colorectal carcinoma-associated protein antibody, DKFZp762B1512 antibody, FLJ21439 antibody, KIAA1840 antibody, Spastic paraplegia 11 (autosomal recessive) antibody, Spastic paraplegia 11 antibody, Spastic paraplegia 11 protein antibody, Spatacsin antibody, SPG 11 antibody, Spg11 antibody, SPTCS_HUMAN antibody
-
UniProt
- Q96JI7
Antigène
-